In Part 1, we talked about why the current tools fail many women. Why mammograms miss tumors and why we rely on the “smush test.” It was frustrating, but it was validating.

Now, in Part 2, we turn the page from the problem to the solution.

Dr. Peter Kuhn isn’t just analyzing why we miss cancer; he is building the tool to catch it before it even forms a tumor. It’s called The Pink Test, and it relies on liquid biopsies—finding traces of cancer in your blood using high-level physics and AI.

This isn’t just science fiction. It is the roadmap to a world where we don’t wait for a lump to tell us our life is about to change.

In this episode, we cover:

• The Pink Test: What is a “liquid biopsy” and how does it find what scans miss?
• Scare vs. Scan: Moving from the terror of finding a lump to the routine data of a blood draw.
• AI & Physics: How Peter is using “math” to solve the biological problem of cancer.
• Participation: Why Peter needs all 330 million of us to help finish the job.

Resources:

• Read the full breakdown in the newsletter: www.kcapodcast.com
• Learn more about Dr. Peter Kuhn’s work at the USC Michelson Center.

Rate, Review & Follow: If this episode gave you hope, please help us reach more people by rating and reviewing the show. It takes less than 60 seconds and helps others find these stories of science and strength. Click here, scroll to the bottom, tap to rate with five stars, and select “Write a Review.”